Table 1.
Fatty-acid profile used for diet supplementation in the infant cohort. MCT—medium-chain triglycerides.
| Figure 12. | FormulaidTM | MCT NM |
|---|---|---|
| Lauric Acid (C12:0) | 1.3 | - |
| Myristic Acid (C14:0) | 3.1 | 0.1 |
| Palmitic Acid (C16:0) | 14.2 | 16.3 |
| Palmitoleic Acid (C16:1 n-7) | 0.5 | 0.2 |
| Stearic Acid (C18:0) | 4.5 | 2.7 |
| Oleic Acid (C18:1 n-9) | 20.8 | 20.4 |
| Linoleic Acid (C18:2 n-6) | 27.5 | 53.5 |
| Linolenic Acid (C18:3 n-6) | 1.0 | - |
| Alpha Linoleic Acid (C18:3 n-3) | 3.0 | 4.6 |
| Arachidic Acid (C20:0) | 0.4 | 0.3 |
| Gondoic Acid (C20:1 n-9) | 0.2 | 0.3 |
| Eicosadienoic Acid (C20:2 n-6) | 0.2 | - |
| Eicosatrienoic Acid (C20:3 n-6) | 0.9 | - |
| Arachidonic Acid (C20:4 n-6) | 13.5 | - |
| Eicosapentaenoic Acid (C20:5 n-3) | 0.1 | - |
| Behenic Acid (C22:0) | 0.5 | - |
| Docosahexaenoic Acid (C22:6 n-3) | 6.3 | - |
| Lignoceric Acid (C24:0) | 0.4 | - |
FormulaidTM was used in the arachidonic acid/docosahexaenoic acid (ARA:DHA-S) infant group; MCT NM was used in MCT-S infant group.